New nerve pain drug ASCT-83 enters first human safety trial
NCT ID NCT07363395
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests whether a new drug called ASCT-83 is safe for people with nerve pain. It involves 72 healthy adults who will receive either the drug or a placebo. The study will also measure how the drug moves through the body. Results will help decide safe doses for future trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROPATHIC PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nucleus Network Minneapolis Clinic
RECRUITINGSaint Paul, Minnesota, 55114-5000, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a skin injection of ketamine and lidocaine tame CRPS pain?
- Could painkillers quietly disrupt your hormones?
- Alzheimer's drug may stop chronic pain after breast surgery
- Pepper-Based patch tested against Kids' chronic nerve pain
- Could a botox shot in the mouth silence stubborn nerve pain?
- Zapping pain without drugs: brain stimulation put to the test for nerve pain